Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab. - Jackson DJ; Burhan H; Rupani H; Pfeffer PE; Clifton IJ; Faruqi S; Dhariwal J; Patel P; Morris T; Lipworth J; Watt M; Lupton C; et al. (Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2024)